T. Rowe Price holds 9.2% of Tenet Healthcare

T. Rowe Price Associates, Inc. reported beneficial ownership of 7,954,926 shares of Tenet Healthcare Corp common stock, representing 9.2% of the class.

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. reported beneficial ownership of 7,954,926 shares of Tenet Healthcare Corp common stock, representing 9.2% of the class. The firm reported sole voting power over 7,857,098 shares and sole dispositive power over 7,954,926 shares, with no shared voting or dispositive power.

T. Rowe Price Associates stated that this filing should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.

Key Figures

Beneficially owned shares: 7,954,926 shares Percent of class owned: 9.2% Sole voting power: 7,857,098 shares +1 more

4 metrics

Beneficially owned shares 7,954,926 shares Common stock of Tenet Healthcare Corp reported as beneficially owned by T. Rowe Price Associates

Percent of class owned 9.2% Percentage of Tenet Healthcare common stock class reported as beneficially owned

Sole voting power 7,857,098 shares Shares of Tenet Healthcare for which T. Rowe Price Associates has sole power to vote

Sole dispositive power 7,954,926 shares Shares of Tenet Healthcare for which T. Rowe Price Associates has sole power to dispose

Key Terms

Schedule 13G/A, beneficial owner, sole voting power, sole dispositive power

4 terms

Schedule 13G/A regulatory

"Form type identified as SCHEDULE 13G/A for Tenet Healthcare Corp"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial owner financial

"shall not be construed as an admission that Price Associates is the beneficial owner"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole voting power financial

"Sole Voting Power 7,857,098.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 7,954,926.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Tenet Healthcare (THC) shares does T. Rowe Price Associates report owning?

T. Rowe Price Associates reports beneficial ownership of 9.2% of Tenet Healthcare Corp common stock, representing 7,954,926 shares. This percentage reflects its reported holdings as of the date referenced in the filing.

How many Tenet Healthcare (THC) shares does T. Rowe Price Associates have voting power over?

T. Rowe Price Associates reports sole voting power over 7,857,098 shares of Tenet Healthcare common stock and no shared voting power. This indicates it can vote those shares without needing another party’s consent.

What is the total number of Tenet Healthcare (THC) shares beneficially owned by T. Rowe Price Associates?

T. Rowe Price Associates reports beneficial ownership of 7,954,926 Tenet Healthcare common shares. It also reports sole dispositive power over the same 7,954,926 shares, with no shared dispositive power.

Does T. Rowe Price Associates claim beneficial ownership of its reported Tenet Healthcare (THC) shares?

T. Rowe Price Associates explicitly states that this report shall not be construed as an admission that it is the beneficial owner of the Tenet Healthcare securities referenced, and such beneficial ownership is expressly denied in the text.

What type of security in Tenet Healthcare (THC) is reported in this Schedule 13G/A?

The filing covers common stock of Tenet Healthcare Corp, identified by CUSIP 88033G407. T. Rowe Price Associates reports its beneficial ownership and voting and dispositive powers over this class of securities.

Where is T. Rowe Price Associates, Inc. organized and what is its reported citizenship in relation to Tenet Healthcare (THC)?

T. Rowe Price Associates is reported with citizenship or place of organization: Maryland. Its principal business office is listed as 1307 Point Street, Baltimore, MD 21231, in connection with this Tenet Healthcare common stock ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 10:38 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

TENET HEALTHCARE CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

88033G407

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 88033G407

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,857,098.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,954,926.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,954,926.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.2 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TENET HEALTHCARE CORP
(b)	Address of issuer's principal executive offices: 14201 DALLAS PARKWAY, DALLAS, TX, 75254
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 88033G407
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 7954926
(b)	Percent of class: 9.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 7857098
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 7954926
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	08/14/2026